ERIS Lifesciences consolidated net profit rises 31.23% in the September 2025 quarter

Sales rise 6.93% to Rs 790.15 crore

Net profit of ERIS Lifesciences rose 31.23% to Rs 120.19 crore in the quarter ended September 2025 as against Rs 91.59 crore during the previous quarter ended September 2024. Sales rose 6.93% to Rs 790.15 crore in the quarter ended September 2025 as against Rs 738.95 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	790.15	738.95	7
OPM %	36.48	35.80	-
PBDT	241.75	209.59	15
PBT	172.67	129.11	34
NP	120.19	91.59	31

Powered by Capital Market - Live News